Response of Fibroblastic Rheumatism to Infliximab
Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of c...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2009/715729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562503112982528 |
|---|---|
| author | Ricardo Romiti Mauricio Levy Neto Marcello Menta Simonsen Nico |
| author_facet | Ricardo Romiti Mauricio Levy Neto Marcello Menta Simonsen Nico |
| author_sort | Ricardo Romiti |
| collection | DOAJ |
| description | Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed. |
| format | Article |
| id | doaj-art-d8fa81949cfa4164994d9eb1861c912d |
| institution | Kabale University |
| issn | 1687-6105 1687-6113 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Dermatology Research and Practice |
| spelling | doaj-art-d8fa81949cfa4164994d9eb1861c912d2025-02-03T01:22:31ZengWileyDermatology Research and Practice1687-61051687-61132009-01-01200910.1155/2009/715729715729Response of Fibroblastic Rheumatism to InfliximabRicardo Romiti0Mauricio Levy Neto1Marcello Menta Simonsen Nico2Departments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilDepartments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilDepartments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilOnset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.http://dx.doi.org/10.1155/2009/715729 |
| spellingShingle | Ricardo Romiti Mauricio Levy Neto Marcello Menta Simonsen Nico Response of Fibroblastic Rheumatism to Infliximab Dermatology Research and Practice |
| title | Response of Fibroblastic Rheumatism to Infliximab |
| title_full | Response of Fibroblastic Rheumatism to Infliximab |
| title_fullStr | Response of Fibroblastic Rheumatism to Infliximab |
| title_full_unstemmed | Response of Fibroblastic Rheumatism to Infliximab |
| title_short | Response of Fibroblastic Rheumatism to Infliximab |
| title_sort | response of fibroblastic rheumatism to infliximab |
| url | http://dx.doi.org/10.1155/2009/715729 |
| work_keys_str_mv | AT ricardoromiti responseoffibroblasticrheumatismtoinfliximab AT mauriciolevyneto responseoffibroblasticrheumatismtoinfliximab AT marcellomentasimonsennico responseoffibroblasticrheumatismtoinfliximab |